KIF3A rs11650680: Understanding Skin Barrier and Allergy Risk
The rs11650680 variant is a genetic change located within the KIF3A gene, which plays a critical role in maintaining the skin's protective barrier. Research suggests this variant may be associated with an increased risk of atopic dermatitis and the subsequent development of food allergies, a progression often referred to as the atopic march.
What each genotype means
Typical skin barrier profile
This genotype represents the most common form of the KIF3A gene at this location. Research suggests that individuals with this profile may have a lower risk of skin barrier dysfunction compared to those carrying the T allele, potentially reducing the likelihood of progression along the atopic march toward atopic dermatitis and subsequent food allergies.
This is the most common genotype in European populations, where the minor allele frequency is approximately 0.31.
Increased skin barrier sensitivity
Carrying one copy of the T allele is associated with a higher risk of skin barrier dysfunction. This genetic variation may allow environmental allergens to penetrate the skin more easily, which is a known factor that can contribute to the development of atopic dermatitis and the progression toward food allergies and asthma in children.
This heterozygous genotype is found in a significant portion of the population, reflecting the common nature of the T allele in European and East Asian ancestries.
Elevated skin barrier risk
Individuals with this genotype carry two copies of the T allele, which has been linked to an increased risk of a dysfunctional skin barrier. While this genetic association is considered limited in its predictive power, it is recognized as a factor that may facilitate the entry of allergens through the skin, potentially increasing susceptibility to the atopic march.
This genotype is less common than the CC or CT profiles, occurring at a frequency consistent with the reported minor allele frequencies in global populations.
What is rs11650680?
The variant rs11650680 is a single nucleotide polymorphism (SNP) located on chromosome 17. In genetic terms, it is classified as an intronic regulatory variant, meaning it sits within a non-coding region of the KIF3A gene. While it does not directly alter the protein sequence, such variants often influence how much of a protein is produced or when it is expressed in specific tissues. Because it is located in a regulatory region, researchers study this SNP to understand how it might affect the structural integrity of the skin. By analyzing its position in the genome, scientists can investigate whether this specific change contributes to the molecular mechanisms that lead to skin barrier dysfunction, which is a hallmark of various allergic conditions.
The Role of the KIF3A Gene
The KIF3A gene provides instructions for making a protein that is a subunit of kinesin-2, a motor protein essential for intracellular transport. In the context of skin health, KIF3A is vital for maintaining the homeostasis of the epidermal barrier. Research has shown that decreased expression or function of KIF3A in skin cells can lead to increased transepidermal water loss and the dysregulation of other genes necessary for a healthy skin barrier. When this barrier is compromised, it becomes easier for environmental allergens to penetrate the skin, potentially triggering immune responses. This dysfunction is a key factor in the development of atopic dermatitis, a chronic inflammatory skin condition characterized by severe itchiness and rash, which often serves as the starting point for the atopic march.
Research and Evidence Strength
Current scientific literature associates rs11650680 with skin barrier dysfunction and an increased risk of atopic dermatitis. Studies suggest that this variant may contribute to the progression of the atopic march, where early-life skin issues are followed by the development of food allergies and asthma. However, it is important to note that the evidence strength for this specific SNP is currently considered limited. While genetic associations have been observed in various cohorts, the biological impact of this single variant is likely part of a much larger, complex interaction between multiple genes and environmental factors. Because atopic diseases are multifactorial, possessing this variant does not guarantee the development of allergies, and many individuals with the variant remain healthy. Further research is required to fully elucidate the functional consequences of this SNP.
What You Can Do With This Information
Understanding your genetic predispositions can be an educational tool, but it is not a medical diagnosis. If you are concerned about skin health, food allergies, or the development of atopic conditions, the most effective approach is to consult with a board-certified dermatologist or an allergist. These professionals can evaluate your clinical symptoms, medical history, and environmental exposures to provide personalized care. Genetic information should never be used to self-diagnose or to make changes to your medical treatment or diet without professional guidance. If you are currently managing an allergic condition, continue to follow the treatment plan prescribed by your healthcare provider. Genetic variants like rs11650680 represent only one piece of a complex puzzle, and clinical assessment remains the gold standard for managing health.
How common is this variant?
The minor allele frequency for rs11650680 is approximately 0.31 in European populations and 0.19 in East Asian populations, indicating that the variant is relatively common across these groups.
Frequently asked questions
Does having the rs11650680 variant mean I will develop food allergies?
No, having this variant does not mean you will develop food allergies. It is only one of many genetic and environmental factors that contribute to the risk of developing atopic conditions.
Can I change my KIF3A gene expression?
Genetic variants are inherited and cannot be changed. However, managing skin health through proper hydration and avoiding known triggers can help support your skin barrier function.
Is rs11650680 a diagnostic test for eczema?
No, this SNP is not used as a diagnostic test. Eczema is diagnosed by healthcare professionals based on clinical symptoms and physical examinations.
Where can I find more information about my specific genetic results?
You should discuss any genetic reports with a qualified healthcare provider or a genetic counselor. They can help interpret your results in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11650680?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in KIF3A
Regulatory variant at 5q31.1 altering KIF3A expression, associated with atopic dermatitis and asthma risk.
A functional SNP in the KIF3A gene that regulates gene transcription and is linked to impaired skin hydration and increased susceptibility to eczema.